- $96.00m
- $244.00m
- $278.30m
- 42
- 61
- 17
- 33
Annual balance sheet for Cardlytics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 293 | 233 | 122 | 91.8 | 65.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 86.6 | 117 | 120 | 126 | 107 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 386 | 359 | 250 | 224 | 178 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 24.6 | 21.5 | 12.5 | 10.6 | 8.94 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 423 | 1,264 | 691 | 574 | 393 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 81.3 | 327 | 249 | 171 | 149 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 265 | 573 | 480 | 439 | 323 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 157 | 691 | 212 | 135 | 70 |
Total Liabilities & Shareholders' Equity | 423 | 1,264 | 691 | 574 | 393 |
Total Common Shares Outstanding |